Inhouse ConsultantDr. Deepan Rajamanickam
Dr. Deepan Rajamanickam MD, DM
Qualification: M. D. General Medicine, D. M. Medical Oncology
Designation: Senior consultant
Department: Department of Medical Oncology, Hematolymphoid malignancies and Bone marrow transplant
About the Doctor
Hard working, Sports person, Dedicated, Organised.
Experience
Senior resident in TMH mumbai – 1 Year.
DM medical oncology course, TMH – 3 Years.
Junior consultant, Medical oncology TMH – 1 Year.
Junior consultant, Medical oncology, Global Hospital, Parel, Mumbai for 6 Months.
Senior Consultant in Thangam Cancer Center since Feb 2017.
Research
Lomustine, cytarabine, cyclophosphamide, etoposide – An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors Journal of Cancer research and therapeutics, January 2018.
Paraneoplastic (non-metastatic) adrenal insufficiency preceded the onset of primary lung cancer by 12 weeks Journal of BMJ , January 2009.
Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer – An Indian exploratory analysis study South Asian J Cancer 2019.
Ratio of total leukocyte count to C-reactive protein: does it help to differentiate infectious fever from engraftment fever in patients undergoing autologous hematopoietic stem cell transplant? Journal of cellular theraphy and transplantation 2020.
Multidrug resistant tuberculosis co-existing with aspergilloma and invasive aspergillosis in a 50 year old diabetic woman: a case report 2008.
Over expression of brain and acute leukemia, cytoplasmic and ETS-related gene is associated with poor outcome in acute myeloid leukemia 2020.
Treatment pattern post-osimertinib failure in EGFR mutated NSCLC in India-CRSF202002 study 2021.
Academic
Multiple lectures and panel based discussions in various national conferences.
Posters and abstract in international ASH conference.
Conducting awareness camps and basic talks in oncology for GP s and general public.